Tags

Type your tag names separated by a space and hit enter

Relationship between increasing body weight, insulin resistance, inflammation, adipocytokine leptin, and coronary circulatory function.
J Am Coll Cardiol. 2006 Mar 21; 47(6):1188-95.JACC

Abstract

OBJECTIVES

We sought to evaluate effects of obesity, insulin resistance, and inflammation on coronary circulatory function and its relationship to leptin plasma levels.

BACKGROUND

It is not known whether obesity, commonly paralleled by insulin resistance, inflammation, and leptin, is independently associated with coronary circulatory dysfunction.

METHODS

Myocardial blood flow (MBF) responses to cold pressor test (CPT) and pharmacologic vasodilation was measured with positron emission tomography and 13N-ammonia. Study participants were divided into three groups based on their body mass index (BMI, kg/m2): control, 20 < or = BMI <25 (n = 19); overweight, 25 < or = BMI <30 (n = 21); and obese, BMI >30 (n = 32).

RESULTS

Body mass index was significantly correlated to the Homeostasis Model Assessment Index of insulin resistance and C-reactive protein levels (r = 0.60 and r = 0.47, p < 0.0001). Compared with control subjects, endothelium-related change in MBF (DeltaMBF) to CPT progressively declined in overweight and obese groups (0.32 +/- 0.09 vs. 0.21 +/- 0.19 and 0.07 +/- 0.16 ml/g/min; p < 0.03 and p < 0.0001). The dipyridamole-induced total vasodilator capacity was significantly lower in obese than in control subjects (1.77 +/- 0.51 vs. 2.04 +/- 0.37 ml/g/min, p < 0.02). On multivariate analysis, BMI (p < 0.012) and age (p < 0.035) were significant independent predictors of DeltaMBF. Finally, only in the obese group leptin plasma levels significantly correlated with DeltaMBF (r = 0.37, p < 0.036).

CONCLUSIONS

Increased body weight is independently associated with abnormal coronary circulatory function that progresses from an impairment in endothelium-related coronary vasomotion in overweight individuals to an impairment of the total vasodilator capacity in obese individuals. The findings that elevated leptin plasma levels in patients that are obese might exert beneficial effects on the coronary endothelium to counterbalance the adverse effects of increases in body weight on coronary circulatory function should be tested.

Authors+Show Affiliations

Department of Molecular, David Geffen School of Medicine at UCLA, University of California at Los Angeles, Los Angeles, California 90095-1735, USA.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, N.I.H., Extramural

Language

eng

PubMed ID

16545651

Citation

Schindler, Thomas H., et al. "Relationship Between Increasing Body Weight, Insulin Resistance, Inflammation, Adipocytokine Leptin, and Coronary Circulatory Function." Journal of the American College of Cardiology, vol. 47, no. 6, 2006, pp. 1188-95.
Schindler TH, Cardenas J, Prior JO, et al. Relationship between increasing body weight, insulin resistance, inflammation, adipocytokine leptin, and coronary circulatory function. J Am Coll Cardiol. 2006;47(6):1188-95.
Schindler, T. H., Cardenas, J., Prior, J. O., Facta, A. D., Kreissl, M. C., Zhang, X. L., Sayre, J., Dahlbom, M., Licinio, J., & Schelbert, H. R. (2006). Relationship between increasing body weight, insulin resistance, inflammation, adipocytokine leptin, and coronary circulatory function. Journal of the American College of Cardiology, 47(6), 1188-95.
Schindler TH, et al. Relationship Between Increasing Body Weight, Insulin Resistance, Inflammation, Adipocytokine Leptin, and Coronary Circulatory Function. J Am Coll Cardiol. 2006 Mar 21;47(6):1188-95. PubMed PMID: 16545651.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Relationship between increasing body weight, insulin resistance, inflammation, adipocytokine leptin, and coronary circulatory function. AU - Schindler,Thomas H, AU - Cardenas,Jerson, AU - Prior,John O, AU - Facta,Alvaro D, AU - Kreissl,Michael C, AU - Zhang,Xiao-Li, AU - Sayre,James, AU - Dahlbom,Magnus, AU - Licinio,Julio, AU - Schelbert,Heinrich R, Y1 - 2006/02/23/ PY - 2005/08/06/received PY - 2005/09/30/revised PY - 2005/10/10/accepted PY - 2006/3/21/pubmed PY - 2006/5/17/medline PY - 2006/3/21/entrez SP - 1188 EP - 95 JF - Journal of the American College of Cardiology JO - J Am Coll Cardiol VL - 47 IS - 6 N2 - OBJECTIVES: We sought to evaluate effects of obesity, insulin resistance, and inflammation on coronary circulatory function and its relationship to leptin plasma levels. BACKGROUND: It is not known whether obesity, commonly paralleled by insulin resistance, inflammation, and leptin, is independently associated with coronary circulatory dysfunction. METHODS: Myocardial blood flow (MBF) responses to cold pressor test (CPT) and pharmacologic vasodilation was measured with positron emission tomography and 13N-ammonia. Study participants were divided into three groups based on their body mass index (BMI, kg/m2): control, 20 < or = BMI <25 (n = 19); overweight, 25 < or = BMI <30 (n = 21); and obese, BMI >30 (n = 32). RESULTS: Body mass index was significantly correlated to the Homeostasis Model Assessment Index of insulin resistance and C-reactive protein levels (r = 0.60 and r = 0.47, p < 0.0001). Compared with control subjects, endothelium-related change in MBF (DeltaMBF) to CPT progressively declined in overweight and obese groups (0.32 +/- 0.09 vs. 0.21 +/- 0.19 and 0.07 +/- 0.16 ml/g/min; p < 0.03 and p < 0.0001). The dipyridamole-induced total vasodilator capacity was significantly lower in obese than in control subjects (1.77 +/- 0.51 vs. 2.04 +/- 0.37 ml/g/min, p < 0.02). On multivariate analysis, BMI (p < 0.012) and age (p < 0.035) were significant independent predictors of DeltaMBF. Finally, only in the obese group leptin plasma levels significantly correlated with DeltaMBF (r = 0.37, p < 0.036). CONCLUSIONS: Increased body weight is independently associated with abnormal coronary circulatory function that progresses from an impairment in endothelium-related coronary vasomotion in overweight individuals to an impairment of the total vasodilator capacity in obese individuals. The findings that elevated leptin plasma levels in patients that are obese might exert beneficial effects on the coronary endothelium to counterbalance the adverse effects of increases in body weight on coronary circulatory function should be tested. SN - 1558-3597 UR - https://www.unboundmedicine.com/medline/citation/16545651/Relationship_between_increasing_body_weight_insulin_resistance_inflammation_adipocytokine_leptin_and_coronary_circulatory_function_ DB - PRIME DP - Unbound Medicine ER -